FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W81392257> ?p ?o ?g. }

• W81392257 endingPage "438" @default.
• W81392257 startingPage "430" @default.
• W81392257 abstract "Rationale and Objectives To determine whether quantitative dynamic contrast-enhanced (DCE) and diffusion-weighted (DW) magnetic resonance imaging (MRI) features can discriminate malignant from benign axillary lymph nodes (ALNs) identified as suspicious on clinical breast MRI in patients newly diagnosed with breast cancer. Materials and Methods After approval from institutional review board, all clinical breast MR examinations performed from March 2006 through January 2010 describing at least one morphologically suspicious ipsilateral ALN in patients with newly diagnosed breast cancer were identified. Each suspicious ALN underwent ultrasound-guided core needle biopsy, and nodes with benign results were subsequently sampled surgically. Quantitative DCE and DW MRI parameters (diameters, volume, enhancement kinetics, and apparent diffusion coefficients [ADC]) were measured for each suspicious ALN and a representative contralateral normal node, and each feature was compared between the ALN groups (normal, benign, and malignant). Results Thirty-four suspicious ALNs (18 malignant and 16 benign) and 34 contralateral normal-appearing ALNs were included. Suspicious malignant and benign nodes exhibited larger size, greater volume, and lower ADCs than normal ALNs (P < .05). Among suspicious ALNs, the only quantitative measure that discriminated between malignant from benign outcome was percent of ALN demonstrating washout kinetics (P = .02). Conclusions In ALNs deemed morphologically suspicious on breast MRI, quantitative MRI features show little value in identifying those with malignant etiology. To determine whether quantitative dynamic contrast-enhanced (DCE) and diffusion-weighted (DW) magnetic resonance imaging (MRI) features can discriminate malignant from benign axillary lymph nodes (ALNs) identified as suspicious on clinical breast MRI in patients newly diagnosed with breast cancer. After approval from institutional review board, all clinical breast MR examinations performed from March 2006 through January 2010 describing at least one morphologically suspicious ipsilateral ALN in patients with newly diagnosed breast cancer were identified. Each suspicious ALN underwent ultrasound-guided core needle biopsy, and nodes with benign results were subsequently sampled surgically. Quantitative DCE and DW MRI parameters (diameters, volume, enhancement kinetics, and apparent diffusion coefficients [ADC]) were measured for each suspicious ALN and a representative contralateral normal node, and each feature was compared between the ALN groups (normal, benign, and malignant). Thirty-four suspicious ALNs (18 malignant and 16 benign) and 34 contralateral normal-appearing ALNs were included. Suspicious malignant and benign nodes exhibited larger size, greater volume, and lower ADCs than normal ALNs (P < .05). Among suspicious ALNs, the only quantitative measure that discriminated between malignant from benign outcome was percent of ALN demonstrating washout kinetics (P = .02). In ALNs deemed morphologically suspicious on breast MRI, quantitative MRI features show little value in identifying those with malignant etiology." @default.
• W81392257 created "2016-06-24" @default.
• W81392257 creator A5010926549 @default.
• W81392257 creator A5051360855 @default.
• W81392257 creator A5073988968 @default.
• W81392257 creator A5079030710 @default.
• W81392257 creator A5087244073 @default.
• W81392257 creator A5087358853 @default.
• W81392257 creator A5088550708 @default.
• W81392257 date "2015-04-01" @default.
• W81392257 modified "2023-09-26" @default.
• W81392257 title "Suspicious Axillary Lymph Nodes Identified on Clinical Breast MRI in Patients Newly Diagnosed with Breast Cancer" @default.
• W81392257 cites W1506014272 @default.
• W81392257 cites W1883441689 @default.
• W81392257 cites W1977451164 @default.
• W81392257 cites W2012210088 @default.
• W81392257 cites W2021917147 @default.
• W81392257 cites W2031534035 @default.
• W81392257 cites W2043226254 @default.
• W81392257 cites W2049532444 @default.
• W81392257 cites W2050851303 @default.
• W81392257 cites W2051326077 @default.
• W81392257 cites W2053056076 @default.
• W81392257 cites W2067095650 @default.
• W81392257 cites W2077036452 @default.
• W81392257 cites W2083029249 @default.
• W81392257 cites W2096785769 @default.
• W81392257 cites W2115527491 @default.
• W81392257 cites W2117965471 @default.
• W81392257 cites W2122647939 @default.
• W81392257 cites W2133221537 @default.
• W81392257 cites W2138357781 @default.
• W81392257 cites W2148677781 @default.
• W81392257 cites W2155429029 @default.
• W81392257 cites W2169648875 @default.
• W81392257 doi "https://doi.org/10.1016/j.acra.2014.10.010" @default.
• W81392257 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4355079" @default.
• W81392257 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25491740" @default.
• W81392257 hasPublicationYear "2015" @default.
• W81392257 type Work @default.
• W81392257 sameAs 81392257 @default.
• W81392257 citedByCount "23" @default.
• W81392257 countsByYear W813922572016 @default.
• W81392257 countsByYear W813922572017 @default.
• W81392257 countsByYear W813922572018 @default.
• W81392257 countsByYear W813922572019 @default.
• W81392257 countsByYear W813922572020 @default.
• W81392257 countsByYear W813922572021 @default.
• W81392257 countsByYear W813922572022 @default.
• W81392257 countsByYear W813922572023 @default.
• W81392257 crossrefType "journal-article" @default.
• W81392257 hasAuthorship W81392257A5010926549 @default.
• W81392257 hasAuthorship W81392257A5051360855 @default.
• W81392257 hasAuthorship W81392257A5073988968 @default.
• W81392257 hasAuthorship W81392257A5079030710 @default.
• W81392257 hasAuthorship W81392257A5087244073 @default.
• W81392257 hasAuthorship W81392257A5087358853 @default.
• W81392257 hasAuthorship W81392257A5088550708 @default.
• W81392257 hasBestOaLocation W813922572 @default.
• W81392257 hasConcept C121608353 @default.
• W81392257 hasConcept C126322002 @default.
• W81392257 hasConcept C126838900 @default.
• W81392257 hasConcept C142724271 @default.
• W81392257 hasConcept C143409427 @default.
• W81392257 hasConcept C2775934546 @default.
• W81392257 hasConcept C2777111374 @default.
• W81392257 hasConcept C2777649267 @default.
• W81392257 hasConcept C2780472235 @default.
• W81392257 hasConcept C2780849966 @default.
• W81392257 hasConcept C41727105 @default.
• W81392257 hasConcept C530470458 @default.
• W81392257 hasConcept C71924100 @default.
• W81392257 hasConceptScore W81392257C121608353 @default.
• W81392257 hasConceptScore W81392257C126322002 @default.
• W81392257 hasConceptScore W81392257C126838900 @default.
• W81392257 hasConceptScore W81392257C142724271 @default.
• W81392257 hasConceptScore W81392257C143409427 @default.
• W81392257 hasConceptScore W81392257C2775934546 @default.
• W81392257 hasConceptScore W81392257C2777111374 @default.
• W81392257 hasConceptScore W81392257C2777649267 @default.
• W81392257 hasConceptScore W81392257C2780472235 @default.
• W81392257 hasConceptScore W81392257C2780849966 @default.
• W81392257 hasConceptScore W81392257C41727105 @default.
• W81392257 hasConceptScore W81392257C530470458 @default.
• W81392257 hasConceptScore W81392257C71924100 @default.
• W81392257 hasFunder F4320332161 @default.
• W81392257 hasIssue "4" @default.
• W81392257 hasLocation W813922571 @default.
• W81392257 hasLocation W813922572 @default.
• W81392257 hasLocation W813922573 @default.
• W81392257 hasLocation W813922574 @default.
• W81392257 hasOpenAccess W81392257 @default.
• W81392257 hasPrimaryLocation W813922571 @default.
• W81392257 hasRelatedWork W1517187278 @default.
• W81392257 hasRelatedWork W2073575878 @default.
• W81392257 hasRelatedWork W2098289555 @default.
• W81392257 hasRelatedWork W2124850242 @default.
• W81392257 hasRelatedWork W2508382190 @default.

• next